ZEUS Trial Questions Simplicity of Targeting Inflammation in Heart Disease

The ZEUS clinical trial presents new findings that challenge previous assumptions about targeting inflammation to reduce cardiovascular disease risk. While inflammation is known to contribute causally to heart disease, the trial suggests that therapeutic approaches may be more complex than initially believed.

Originally published by gnews